Canlyniadau Chwilio - Tong, Lin-jiang

DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro gan Guo, Xiao-bin, Chen, Xian-jie, Tong, Lin-jiang, Peng, Xia, Huang, Min, Liu, Hong-chun, Liu, Hong, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition gan Dai, Mei, Miao, Ze-Hong, Ren, Xuan, Tong, Lin-Jiang, Yang, Na, Li, Ting, Lin, Li-Ping, Shen, Yue-Mao, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

GA3, a new gambogic acid derivative, exhibits potent antitumor activities in vitro via apoptosis-involved mechanisms gan Xie, Hua, Qin, Yu-xin, Zhou, Yun-long, Tong, Lin-jiang, Lin, Li-ping, Geng, Mei-yu, Duan, Wen-hu, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Characterization of the conversion between CD133(+) and CD133(-) cells in colon cancer SW620 cell line gan Feng, Jian-Ming, Miao, Ze-Hong, Jiang, Yi, Chen, Yi, Li, Jia-Xin, Tong, Lin-Jiang, Zhang, Jin, Huang, Yi-Ran, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent... gan Lai, Meng-zhen, Song, Pei-ran, Dou, Dou, Diao, Yan-yan, Tong, Lin-jiang, Zhang, Tao, Xie, Hua, Li, Hong-lin, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Anti-proliferative effects, cell cycle G(2)/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines gan Lu, Da Yong, Huang, Min, Xu, Cheng Hui, Yang, Wei Yi, Hu, Chao Xin, Lin, Li Ping, Tong, Lin Jiang, Li, Mei Hong, Lu, Wei, Zhang, Xiong Wen, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Naphthalimides Induce G(2) Arrest Through the ATM-Activated Chk2-Executed Pathway in HCT116 Cells gan Zhu, Hong, Miao, Ze-Hong, Huang, Min, Feng, Jian-Ming, Zhang, Zhi-Xiang, Lu, Jin-Jian, Cai, Yu-Jun, Tong, Lin-Jiang, Xu, Yu-Fang, Qian, Xu-Hong, Ding, Jian

Cael y testun llawn Cael y testun llawn

Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide gan Zhou, Zhao-Li, Luo, Zhi-Guo, Yu, Bing, Jiang, Yi, Chen, Yi, Feng, Jian-Ming, Dai, Mei, Tong, Lin-Jiang, Li, Zheng, Li, Yuan-Chao, Ding, Jian, Miao, Ze-Hong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Drug Transporter-independent Liver Cancer Cell Killing by a Marine Steroid Methyl Spongoate via Apoptosis Induction gan Jiang, Yi, Miao, Ze-Hong, Xu, Lei, Yu, Bing, Gong, Jing-Xu, Tong, Lin-Jiang, Chen, Yi, Zhou, Zhao-Li, Liu, Hong-Chun, Wang, Yi, Guo, Yue-Wei, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Establishment of platform for screening insulin-like growth factor-1 receptor inhibitors and evaluation of novel inhibitors gan Tong, Lin-jiang, Xie, Hua, Peng, Ting, Liu, Xiao-feng, Xin, Xian-liang, Huang, Xun, Chen, Si-meng, Liu, Hong-yan, Li, Hong-lin, Geng, Mei-yu, Yin, Ming, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin gan Peng, Ting, Wu, Jian-rui, Tong, Lin-jiang, Li, Meng-yuan, Chen, Fang, Leng, Yi-xin, Qu, Rong, Han, Kun, Su, Yi, Chen, Yi, Duan, Wen-hu, Xie, Hua, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo gan Li, Meng-yuan, Lv, Yong-cong, Tong, Lin-jiang, Peng, Ting, Qu, Rong, Zhang, Tao, Sun, Yi-ming, Chen, Yi, Wei, Li-xin, Geng, Mei-yu, Duan, Wen-hu, Xie, Hua, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis gan Chen, Zhuo, Tong, Lin-jiang, Tang, Bai-you, Liu, Hong-yan, Wang, Xin, Zhang, Tao, Cao, Xian-wen, Chen, Yi, Li, Hong-lin, Qian, Xu-hong, Xu, Yu-fang, Xie, Hua, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R gan Liu, Ying-Qiang, Wang, Ya-Nan, Lu, Xiao-Yun, Tong, Lin-Jiang, Li, Yan, Zhang, Tao, Xun, Qiu-Ju, Feng, Fang, Chen, Yu-Zhe, Su, Yi, Shen, Yan-Yan, Chen, Yi, Geng, Mei-Yu, Ding, Ke, Li, Yan-Li, Xie, Hua, Ding, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution gan He, Jin-Xue, Wang, Meng, Huan, Xia-Juan, Chen, Chuan-Huizi, Song, Shan-Shan, Wang, Ying-Qing, Liao, Xue-Mei, Tan, Cun, He, Qian, Tong, Lin-Jiang, Wang, Yu-Ting, Li, Xiao-Hua, Su, Yi, Shen, Yan-Yan, Sun, Yi-Ming, Yang, Xin-Ying, Chen, Yi, Gao, Zhi-Wei, Chen, Xiao-Yan, Xiong, Bing, Lu, Xiu-Lian, Ding, Jian, Yang, Chun-Hao, Miao, Ze-Hong

Cael y testun llawn Cael y testun llawn Cael y testun llawn